A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 109.82
GOOG 767.28
MSFT 60.12
BAC 21.85
FB 117.31

Recently Added

SF 49.66
FFIN 44.10
LAZ 42.60
III 3.90
TSO 89.21

Gaining Speed

SF 49.66
FFIN 44.10
III 3.90
LAZ 42.60
MCK 143.79

ZIOPHARM (ZIOP) Starts ZIO-201 Phase 2 in Germ Cell Tumors

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced the start of a multicenter, single arm Phase 2 investigator-sponsored study of palifosfamide (ZIO-201) in patients with recurrent metastatic germ cell (testicular and ovarian) tumors who have relapsed on initial platinum-based therapy and high dose chemotherapy, or patients who are not eligible for...

Read More




Get Alerted When News Hits On This Stock - FREE!